825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Market cap: $6.1B (12/18/2025)
Price: $46.42
Vaxcyte, Inc. Amends Executive Change in Control Agreements
Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
Material Contracts
Vaxcyte Q2 2025 Financial Results and VAX-31 Vaccine Update
Shareholder votes
Reports First Quarter 2025 Financial Results and Provides Business Update
Changes in Board, Management or Compensation
Annual Report to Security Holders
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence